9 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL.
University of Washington
Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors.
Chinese Academy of Sciences
The discovery of small molecule chemical probes of Bcl-X(L) and Mcl-1.
Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A.
Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.
Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules.
University of Maryland
Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro.
Eli Lilly and Company
Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound.
Kyowa Hakko Kogyo Co., Ltd